GH replacement therapy in humans restores basal metabolic rate, reduces visceral fat and waist circumference, and improves lipid profiles, glucose tolerance, and insulin sensitivity, recovering body composition [112] and highlighting GH’s link with central obesity and diabetes. This evidence concerns the gene GH1 and diabetes mellitus.